Jinfeng Qu

Jinan, 250000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

AI-driven transformer-guided fragment-based discovery of Prostaglandin A1 as a multi-target inhibitor of PSAT1, PARP1, and PIK3CA in ovarian cancer.

AI-driven transformer-guided fragment-based discovery of Prostaglandin A1 as a multi-target inhibitor of PSAT1, PARP1, and PIK3CA in ovarian cancer.

Journal: Computational biology and chemistry

Published: April 10, 2026

Global research hotspots and trends on robotic surgery in obstetrics and gynecology: a bibliometric analysis based on VOSviewer.

Global research hotspots and trends on robotic surgery in obstetrics and gynecology: a bibliometric analysis based on VOSviewer.

Journal: Frontiers in surgery

Published: October 06, 2023

Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.

Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.

Journal: Cellular & molecular biology letters

Published: August 18, 2023

Troponin T1 Promotes the Proliferation of Ovarian Cancer by Regulating Cell Cycle and Apoptosis.

Troponin T1 Promotes the Proliferation of Ovarian Cancer by Regulating Cell Cycle and Apoptosis.

Journal: Iranian journal of biotechnology

Published: May 30, 2022

Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3.

Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3.

Journal: Frontiers in oncology

Published: May 19, 2022

Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology.

Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: May 09, 2022

Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment.

Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment.

Journal: Frontiers in oncology

Published: December 03, 2021

Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.

Fucoxanthin prevents cell growth and induces apoptosis in endometrial cancer HEC-1A cells by the inhibition of the PI3K/Akt/mTOR pathway.

Journal: Journal of biochemical and molecular toxicology

Published: August 20, 2021

Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy.

Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy.

Journal: Frontiers in oncology

Published: February 09, 2021

Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2.

Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: May 10, 2018

miR-148b Functions as a Tumor Suppressor by Targeting Endoplasmic Reticulum Metallo Protease 1 in Human Endometrial Cancer Cells.

miR-148b Functions as a Tumor Suppressor by Targeting Endoplasmic Reticulum Metallo Protease 1 in Human Endometrial Cancer Cells.

Journal: Oncology research

Published: March 11, 2018

MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.

MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.

Journal: Die Pharmazie

Published: February 15, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026